Drug-Coated Balloons versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis: A Pair-Wise Meta-Analysis of Randomized Trials

Drug-Coated Balloons versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis: A Pair-Wise Meta-Analysis of Randomized Trials

Objective. This study aimed to compare the effectiveness of drug-coated balloons (DCB) with everolimus-eluting stents (EES) in the treatment of in-stent restenosis (ISR) and the differential relative effect of DCB in patients with drug-eluting stents (DES)-ISR and bare metal stents (BMS)-ISR. Backgr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nina Peng, Wei Liu, Zongzhuang Li, Jun Wei, Xuejun Chen, Wei Wang, Hao Lin
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	Cardiovascular Therapeutics
Online Access:	http://dx.doi.org/10.1155/2020/1042329
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of the Efficacy of Everolimus-Eluting Stents and Paclitaxel-Eluting Balloon Angioplasty for Coronary In-Stent Restenosis: A Systematic Review and Meta-Analysis
by: Zhili Wei, et al.
Published: (2025-06-01)

Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study
by: Sacharias von Koch, et al.
Published: (2024-12-01)

Outcome of Coronary Edge In-stent Restenosis Management by Restenting Versus Drug-Eluting Balloon
by: Yasser Gaber Metwally, et al.
Published: (2024-12-01)

Safety and Efficacy of Cobalt Chromium Everolimus‐Eluting Stents for Treatment of In‐Stent Restenosis: An ILUMIEN IV Substudy
by: Ziad A. Ali, et al.
Published: (2025-06-01)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
by: Yi-Xing Yang, et al.
Published: (2020-01-01)

Paclitaxel eluting stents versus bare metal stents restenosis
by: Ronald Aroche Aportela, et al.
Published: (2021-12-01)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
by: Wen-Juan Xiu, et al.
Published: (2018-01-01)

Extended follow-up of the Essential Pro paclitaxel drug-eluting balloon for in-stent restenosis
by: Lucio Padilla, et al.
Published: (2025-05-01)

Impact of Arterial Stiffness on In-Stent Restenosis in the Era of Drug-Eluting Stents
by: Yiquan Huang, et al.
Published: (2025-06-01)

Risk assessment score for drug eluting stent restenosis
by: Z. A. Gabbasov, et al.
Published: (2018-09-01)

Ureteral stent technology: Drug-eluting stents and stent coatings
by: Luo Yang, et al.
Published: (2015-10-01)

Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents.
by: Da Hyon Lee, et al.
Published: (2017-01-01)

Drug-coated balloon in patients with in-stent restenosis: A prospective observational study
by: Shuvanan Ray, et al.
Published: (2025-03-01)

Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions
by: Liqiang Li, et al.
Published: (2022-09-01)

How real is a threat of late thrombosis for drug-eluting stents? Stent comparison and focus on everolimus
by: V. P. Lupanov, et al.
Published: (2009-10-01)

Drug‐Coated Balloons in In‐Stent Restenosis, a New Standard of Care or Yesterday's News?
by: Nicholas Weight, et al.
Published: (2024-12-01)

Risk Factors and Incidence for In-Stent Restenosis with Drug-Eluting Stent: A Systematic Review and Meta-Analysis
by: Birong Liu, et al.
Published: (2024-12-01)

Risk Factors of Coronary In–Stent Restenosis in Drug-Eluting Stent: A Systematic Review and Meta-Analysis
by: Hotmauli Siahaan, et al.
Published: (2025-07-01)

The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era
by: Chengbin Zheng, et al.
Published: (2019-01-01)

In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes
by: Ganesh Paramasivam, et al.
Published: (2019-12-01)

Biofunctional coatings and drug-coated stents for restenosis therapy
by: Yanghui Wen, et al.
Published: (2024-12-01)

Drug-coated balloons versus drug-eluting stents in patients with small coronary artery disease: an updated meta-analysis
by: Ahmed Abdelaziz, et al.
Published: (2025-04-01)

Drug-eluting balloon versus bare-mental stent and drug-eluting stent for de novo coronary artery disease: A systematic review and meta-analysis of 14 randomized controlled trials.
by: Kongyong Cui, et al.
Published: (2017-01-01)

Impact of Obstructive Sleep Apnea on In-Stent Restenosis in Coronary Heart Disease Patients after Elective Drug-Eluting Stenting
by: Wenjie Yang, et al.
Published: (2025-01-01)

Long term outcomes of drug-coated balloons versus drug-eluting stents in patients with small vessel coronary artery disease
by: Hesham Refaat, et al.
Published: (2025-07-01)

Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
by: Hui Wang, et al.
Published: (2024-12-01)

Clinical Significance of Optical Coherence Tomography–Guided Percutaneous Coronary Intervention for In‐Stent Restenosis Within Drug‐Eluting Stents: Impact on Patient Outcomes
by: Yan Han, et al.
Published: (2024-11-01)

Effect of rapamycin-eluting stents on in-stent restenosis and early inflammatory response in coronary artery narrowing animal models
by: Jianbing Zhang, et al.
Published: (2025-01-01)

Role of early increase in vascular endothelial growth factor-A levels after coronary stenting in the development of drug-eluting in-stent restenosis
by: V. V. Tishko, et al.
Published: (2024-06-01)

Drug-Coated Balloon versus Drug-Eluting Stent in Patients with Small-Vessel Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials
by: Xinying Wu, et al.
Published: (2021-01-01)

Drug-Coated Balloons versus Drug-Eluting Stents for the Treatment of De Novo Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials
by: Jialong Niu, et al.
Published: (2024-12-01)

Abstract 188: Rescue Left Middle Cerebral Artery Stenting With Xience Skypoint Everolimus‐Eluting Stent: Technical Report
by: Raman Singh, et al.
Published: (2023-11-01)

Treatment of In-Stent Restenosis by Excimer Laser Coronary Atherectomy and Drug-Coated Balloon: Serial Assessment with Optical Coherence Tomography
by: Toru Miyazaki, et al.
Published: (2019-01-01)

In-Stent Restenosis and a Drug-Coated Balloon: Insights from a Clinical Therapeutic Strategy on Coronary Artery Diseases
by: Dai-Min Zhang, et al.
Published: (2020-01-01)

MODERN COATING TECHNOLOGIES FOR DRUG ELUTING CORONARY STENTS (REVIEW)
by: E. Y. Zagorulko, et al.
Published: (2019-01-01)

An Interesting Case and Literature Review of a Coronary Stent Fracture in a Current Generation Platinum Chromium Everolimus-Eluting Stent
by: Sammy San Myint Aung, et al.
Published: (2018-01-01)

Fabrication of a 3D printed everolimus-eluting stent made of thermoplastic polyurethane and polylactide
by: M. T. Bekov, et al.
Published: (2024-04-01)

Catlet scoring system as a new predictor for in-stent restenosis in patients with chronic coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent
by: Juan Wang, et al.
Published: (2025-01-01)

Unusual Response of Subclavian In-Stent Restenosis to Balloon Angioplasty in a Patient with HIV
by: Mohammad Atif Rana, et al.
Published: (2015-01-01)

A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study.
by: Anna Franzone, et al.
Published: (2017-01-01)